BPG is committed to discovery and dissemination of knowledge
Editorial Board
Dr. Lekshmi R. Nath joined as Assistant Professor in the Department of Pharmacognosy at Amrita School of Pharmacy in January 2018. She pursued her Ph.D. under Dr. Ruby John Anto, Cancer Research Program, Rajiv Gandhi Centre for Biotechnology (RGCB), an autonomous Research Institution under DBT, Trivandrum, Kerala. Her PhD findings on hepatocellular carcinoma recently received four international patents US, Canada, Japan & South Korea (WO 2017208254 A1, “Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma”). The USFDA has recently granted an orphan drug designation to the small molecule chemotherapeutic Uttroside–B against hepatocellular carcinoma. Q BioMed, a biopharmaceutical company has already started a clinical trial for Uttroside B against Hepatocellular carcinoma. She completed her M.Pharm. from KLE University’s College of Pharmacy, Karnataka (Formerly known as KLES College of Pharmacy) and B.Pharm from Dept. of Pharmaceutical Sciences, MG University, Kottayam. She is having 9 years of research experience at RGCB in the Division of Cancer Reserach Programme. Her research interest includes the study of signalling events associated with the fatty liver to Hepatocellular carcinoma, elucidating the role of phytomedicine in cancer chemoprevention, chemosensitization as well as in chemotherapy. Additionally, she is also interested in exploring the traditional knowledge for infectious disease and liver cancer.